1. Relevant animal models for tumor immunotherapy

   • R. W. Baldwin

   Editorial Pages: 197 - 198

2. The current status of immunotherapy for large bowel cancer

   • S. K. Carter

   Short Review Pages: 199 - 203

3. Differential effect of asparaginase on lymphocyte subpopulations and alleviation of the immunosuppression by lipopolysaccharide

   • W. C. Gordon
   • W. J. Mandy
   • M. D. Prager

   Original Papers Pages: 205 - 209

4. Active immunotherapy of L1210 leukemia with neuraminidase-treated, drug-resistant L1210 sublines

   • A. V. LeFever
   • J. J. Killion
   • G. M. Kollmorgen

   Original Papers Pages: 211 - 217

5. Prevention by the MER tubercle bacillus fraction of immunosuppression induced by cancer chemotherapeutic agents

   • Y. Stupp
   • R. Saltoun
   • D. W. Weiss

   Original Papers Pages: 219 - 226

6. Nonspecific immunoprevention of L1210 leukemia by cord factor (6-6′ dimycolate of trehalose) administered in a metabolizable oil

   • C. Leclerc
   • A. Lamensans
   • E. Lederer

   Original Papers Pages: 227 - 232

7. Therapy of spontaneous pulmonary metastases of a murine mammary carcinoma with anaerobic corynebacteria

   • L. Milas
   • K. Mason
   • H. R. Withers

   Original Papers Pages: 233 - 237

8. Immunotherapy of EL4 lymphoma with reovirus

   • G. Mark Kollmorgen
   • Don C. Cox
   • William A. Sansing

   Original Papers Pages: 239 - 244

9. Production of cytotoxic antibody to a benz(a)pyrene-induced sarcoma in mice receiving xenogeneic antitumor immune RNA

   • D. Fritze
   • D. H. Kern
   • Y. H. Pilch

   Original Papers Pages: 245 - 250

10. Immune competence in breast cancer — Relationship of pretreatment immunologic tests to diagnosis and tumor stage

    • P. M. Bolton
    • C. Teasdale
    • L. E. Hughes

    Original Papers Pages: 251 - 258

11. Partial restoration by in vivo thymosin of E-rosettes and delayed-type hypersensitivity reactions in immunodeficient cancer patients

    • L. A. Schaefer
    • J. U. Gutterman
    • A. L. Goldstein

    Original Papers Pages: 259 - 264

12. Regression of tumors by an endotoxin combined with trehalose mycolates of differing structure

    • E. Ribi
    • K. Takayama
    • M. Kelly

    Original Papers Pages: 265 - 270

13. Trial of BCG immunotherapy in the treatment of resectable squamous cell carcinoma of the bronchus (stages I and II)

    • P. Pouillart
    • G. Mathé
    • R. Parrot

    Short Communication Pages: 271 - 273

14. The current status of clinical immunotherapy as viewed at the 1976 AACR-ASCO meetings

    • S. K. Carter

    Current Affairs Pages: 275 - 281